Annual report pursuant to Section 13 and 15(d)

12. Share-Based Compensation (Details Narrative)

v3.3.1.900
12. Share-Based Compensation (Details Narrative) - USD ($)
 12 Months Ended
Dec. 31, 2015
Dec. 31, 2014
Share based compensation $ 2,594,113 $ 1,513,238
Incremental compensation expense $ 25,008  
FDS Pharma [Member]    
Stock granted for services, shares   3,244,784
Stock granted for services, value   $ 812,000
Employee Stock Options [Member]    
Options granted 16,300,000 1,080,000
Weighted average grant date fair value $ .28 $ .23
Options exercised 0 1,984,080
Proceeds from exercise of stock options $ 0 $ 101,933
Options vested 5,330,000 680,000
Fair value of options vested $ 1,391,450 $ 115,864
Unrecognized compensation expense $ 2,931,117  
Unrecognized compensation expense recognition period 2 years  
Non Employee Stock Options [Member]    
Options granted 1,000,000 480,000
Weighted average grant date fair value $ .40 $ .23
Options exercised 0 0
Options vested 590,000 260,000
Fair value of options vested $ 195,575 $ 62,121
Unrecognized compensation expense $ 263,778  
Unrecognized compensation expense recognition period 1 year 6 months  
Common Stock Awards [Member]    
Stock granted for services, shares 1,135,280 187,406
Stock granted for services, value $ 392,661 $ 102,000
JSOP [Member]    
Share based compensation $ 0 $ 344,905
JSOP awards outstanding 10,688,194 10,688,194